APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148,280 | +22.0% | 3,898 | +192.2% | 0.00% | – |
| Q2 2023 | $121,528 | +40.5% | 1,334 | +1.8% | 0.00% | – |
| Q1 2023 | $86,473 | +134.2% | 1,311 | +83.6% | 0.00% | – |
| Q4 2022 | $36,921 | -87.3% | 714 | -83.3% | 0.00% | -100.0% |
| Q3 2022 | $291,000 | +1611.8% | 4,267 | +1069.0% | 0.00% | – |
| Q2 2022 | $17,000 | -69.6% | 365 | -67.1% | 0.00% | – |
| Q1 2022 | $56,000 | +409.1% | 1,110 | +391.2% | 0.00% | – |
| Q4 2021 | $11,000 | -8.3% | 226 | -34.1% | 0.00% | – |
| Q3 2021 | $12,000 | +33.3% | 343 | +145.0% | 0.00% | – |
| Q2 2021 | $9,000 | +125.0% | 140 | +30.8% | 0.00% | – |
| Q1 2021 | $4,000 | -33.3% | 107 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | +500.0% | 107 | +256.7% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 30 | -58.9% | 0.00% | – |
| Q2 2020 | $2,000 | – | 73 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |